2022 SML FEB 26, 2022
sml_home

Moving in the Right Direction:
An Update on Tardive Dyskinesia


All sessions will be held in Pacific Time (PT).

Saturday, Feb 26th



7:00 am - 8:00 am

The First Movement: Early Recognition and Diagnosis of Tardive Dyskinesia

CME/CE Session


Rajnish Mago, MD

8:00 am - 9:00 am

Industry Symposium

Industry-Sponsored (non-CME/CE)


Sponsored by Intra-Cellular Therapies

9:00 am - 9:30 am

Scientific Poster Session

Industry-Sponsored (non-CME/CE)


Sponsored by Idorsia Pharmaceuticals

9:30 am - 10:30 am

Sitting Still: Strategies for Effective Symptom Management in Tardive Dyskinesia

CME/CE Session


Jonathan Meyer, MD

10:30 am - 11:00 am

Live Panel Q&A

CME/CE Session


Rajnish Mago, MD and Jonathan Meyer, MD

The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. Non-CME/CE events are not part of the scientific program and do not provide CME/CE credit. By opening a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.



Program Faculty





Rajnish Mago, MD


Clinical Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY


Dr. Rajnish Mago is the founder and editor-in-chief of simpleandpractical.com, a website which provides clinical summaries and advanced tips to help mental health clinicians become expert psychopharmacologists. He is a clinical professor of psychiatry at SUNY Upstate Medical University in Syracuse, NY and a clinical assistant professor of psychiatry at the University of Pennsylvania in Philadelphia, PA, where he is the director of the psychopharmacology curriculum.  Dr. Mago was previously a professor of psychiatry and director of the mood disorders program at Thomas Jefferson University in Philadelphia, PA. 

Dr. Mago is equally a clinician, researcher, and educator, with each of these areas informing the others. 

As a clinician, he provides specialized consultation as well as ongoing care to patients with mood disorders, anxiety disorders, and ADHD. 

As a researcher and academic, he has done studies on tools for identifying and assessing symptoms that may be adverse effects, on the treatment of side effects like antidepressant-induced excessive sweating, and on the use of genetic testing to predict who may be more likely to have adverse effects. 

As an educator, his practical guides in psychopharmacology are helping thousands of mental health clinicians in over 70 countries. At the University of Pennsylvania in Philadelphia, PA, where he is a clinical assistant professor, he has designed a four-year psychopharmacology curriculum and personally teaches psychopharmacology to psychiatry residents. He is also actively involved in continuing medical education in his capacity as chair of the education committees for both the Pennsylvania Psychiatric Society and the Philadelphia Psychiatric Society. Dr. Mago is also an associate editor of the periodical Current Psychiatry.

Dr. Mago has been widely recognized for being an exceptional teacher and has received many awards for his teaching. These include the APA’s Nancy C.A. Roeske MD Certificate of Recognition for Excellence in Medical Student Education (2010) and the Irma Bland Award for Excellence in Teaching Residents (2011); the Philadelphia Psychiatric Society’s Daniel Blain Award (2011), the Robert Waelder Award for teaching from the graduating residents (Class of 2012) at Thomas Jefferson University; the Dean’s Award for Excellence in Education at Jefferson Medical College (2013); and the Philadelphia Psychiatric Society’s award for being the Psychiatric Educator of the Year (2014).

read more +




Jonathan M. Meyer, MD


Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA


Dr. Jonathan M. Meyer is a graduate of Stanford University and Harvard Medical School and finished his adult psychiatry residency at Los Angeles County-USC Medical Center. At LA County-USC he subsequently completed fellowships in Consultation/Liaison Psychiatry and Psychopharmacology Research.

In addition to teaching duties at UC San Diego, Dr. Meyer has performed extensive research on the metabolic effects of antipsychotics, and the impact of antipsychotic medications on glucose-insulin homeostasis. Dr. Meyer has published numerous articles and book chapters on various aspects of antipsychotic psychopharmacology including the pharmacokinetics of oral and depot antipsychotics, metabolic effects of atypical antipsychotics, as well as on the health care outcomes in patients with severe mental illness. Dr. Meyer is a national speaker on the subject of side effects and metabolic issues surrounding antipsychotic therapy, is chief editor of Medical Illness and Schizophrenia, now in its 2nd edition, and is the sole author of the chapter on the “Pharmacotherapy of Psychosis and Mania” in the last two editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics.

read more +